INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED

All News Innovative Pharmaceutical Biotech Limited

Equities

399 BMG4783W1073

Delayed Hong Kong S.E. Other stock markets 12:01:51 14/05/2024 pm IST			5-day change	1st Jan Change
0.198 ^HKD	+2.59%		-1.00%	-9.59%

2023	Innovative Pharmaceutical Biotech Returns to Fiscal H1 Attributable Profit	MT
2023	Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Innovative Pharmaceutical Biotech Returns to Fiscal H1 Attributable Profit	30/11	MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2023	29/11	CI
Innovative Pharmaceutical Biotech to Return to Profit in Fiscal H1	28/11	MT
Innovative Pharmaceutical Biotech Limited Provides Unaudited Earnings Guidance for the Six Months Ended 30 September 2023	27/11	CI
Innovative Pharmaceutical Biotech Limited Announces Change of Address of Principal Place of Business in Hong Kong	07/11	CI
Innovative Pharmaceutical Eyes Majority Stake in US Neurotechnology Firm	05/23/05	MT
Innovative Pharmaceutical Biotech Limited entered into a memorandum of understanding to acquire a majority interest in Niraxx Light Therapeutics, Inc.	04/23/04	CI
Innovative Pharmaceutical Plans HK$55.5 Million Bond Issue	28/23/28	MT
Innovative Pharmaceutical to Raise HK$58 Million From Deal with US Firm Genuine Marketing	27/23/27	MT
Innovative Pharmaceutical Biotech Limited announced that it expects to receive HKD 55.5 million in funding	27/23/27	CI
Innovative Pharmaceutical Biotech Limited Appoints Cheng Tak Yiu as an Executive Director	04/23/04	CI
Innovative Pharmaceutical Biotech Incurs Loss in Fiscal Year 2023	30/23/30	MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29/23/29	CI
Innovative Pharmaceutical Biotech Mulls Over Capital Injection in Technical Services Company	20/23/20	MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2022	29/22/29	CI
Innovative Pharmaceutical Biotech Forecasts Swing to Loss in April-September Period	25/22/25	MT
Innovative Pharmaceutical Biotech Limited Provides Group Earnings Guidance for the Six Months Ending 30 September 2022	24/22/24	CI
Innovative Pharmaceutical Biotech Limited Auditor Raises 'Going Concern' Doubt	29/22/29	CI
Innovative Pharmaceutical Biotech Limited Announces Delay in Publication of Audited Annual Results for the Year Ended 31 March 2022	30/22/30	CI
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/22/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Innovative Pharmaceutical Biotech Limited

Equities

399

BMG4783W1073

All News

Filters